11 . 
Oolcetti R, Maestro R, Feriotto G, Pelucchi S, Rizzo S, Boiocchi H. p53 genetic abnormalities in human 
squamous cell carcinomas of the larynx. Oncogene 1990; 6:44-45. 
12. Rodriguez NR, Rowan A, Smith MEF, et al . p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 
1990; 87:7555-7559. 
13. Nigro JM, Baker SJ, Preisinger AC, et al . Mutations in the p53 gene occur in diverse human tumor types. 
Nature 1989; 342:705-708. 
14. Takahashi T, Nau MM, Chiba 1, et al . p53:a frequent target for genetic abnormalities in lung cancer. 
Science 1989; 246:491-494. 
15. Mukhopadhyay T, Cavender A, Tainsky M, Roth JA. Expression of antisense K-ras message in a human lung 
cancer cell line with a spontaneous activated K-ras oncogene alters the transformed phenotype. Proc Amer 
Assoc Cancer Res 1990; 31:304. 
16. Mukhopadhyay T, Cavender AC, Branch CD, Roth JA. Expression and regulation of wild type p53 gene (wtp53) 
in human non-small cell lung cancer (NSCLC) cell lines carrying normal or mutated p53 gene. J Cell 
Biochem 1991; Suppl 15F:22. 
17. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to 
osteopetrosis in mice. Cel 1 1991; 64:693-702. 
18. Chen P-L, Chen Y, Bookstein R, Lee W-H. Genetic mechanisms of tumor suppression by the human p53 gene. 
Science 1990; 250:1576-1580. 
19. Humphrey EW, Smart CR, Winchester DP, et al . National survey of the pattern of care for carcinoma of the 
lung. J Thorac Cardiovasc Surq 1990; 100 (6):837-843. 
20. Perez CA, Stanley K, Rubin P, et al . Patterns of tumor recurrence after definitive irradiation for 
inoperable non-oat cell carcinoma of the lung. Int J Radi at Oncol Biol Phvs 1980; 6:987-994. 
21. Komaki , R., Garden, A.S. and Cundiff, J.H. Endobronchial Radiotherapy. In: Advances in Lung Cancer , 
edited by Roth, J.A., Hong, W.K. and Cox, J.D. Cambridge, MA: Blackwell Scientific Publications, Inc. , 
1992, 
22. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K-ras expression and 
tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 1991; 51:1744-1748. 
23. Debus N, Berdichevsky FB, Gryasnov SM. Effects of antisense ol igodeoxyribonucleotides complementary mRNA 
of the human c-Harvey-ras oncogene on cell proliferation. J Cancer Res Clin Oncol 1990; 116 (Suppl., Part 
l):S-162.(Abstr) 
24. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 
7(9):980-990. 
25. Palmer TD, Hock RA, Osborne WRA, Miller AD. Efficient retrovirus-mediated transfer and expression of a 
human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. 
Proc Natl Acad Sci USA 1987; 84:1055-1059. 
26. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell 
line. Virol 1988; 167:400-406. 
27. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett’s 
epithelium and esophageal cancer. Cancer Res 1991; 51:4495-4499. 
28. Rosenberg SA. TNF/TIL human gene therapy clinical protocol - original protocol, April 23, 1990. Human 
Gene Ther 1990; 1:443-462. 
[290] 
Recombinant DNA Research, Volume 19 
